Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart fai...
Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study
About this item
Full title
Author / Creator
Publisher
England: British Medical Journal Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
England: British Medical Journal Publishing Group
Subjects
More information
Scope and Contents
Contents
Introduction Spironolactone reduces disease and death in patients with severe congestive heart failure and is well tolerated with regard to renal function and serum potassium concentrations. 1 Guidelines recommend taking spironolactone in addition to angiotensin converting enzyme inhibitors and β blockers, 2 3 but since spironolactone can lead to...
Alternative Titles
Full title
Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_261812
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_261812
Other Identifiers
ISSN
0959-8138
E-ISSN
1468-5833,1756-1833
DOI
10.1136/bmj.327.7424.1141
